clinicaltrials.gov
Feed RSS de ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days
Rep les últimes novetats de ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days tan bon punt es publiquin.
Publicacions més recents
Rep ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days allà on llegeixes
Qui segueix ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days també segueix
-
Amylyx Pharmaceuticals, Inc. SEC Filings investors.amylyx.com
-
Alzforum News alzforum.org
-
Search Feed scrip.pharmaintelligence.informa.com
-
-
Eli Lilly and Company SEC Filings investor.lilly.com
-
-
investors.pfizer.com investors.pfizer.com
-
AbbVie Events investors.abbvie.com
Més feeds RSS per explorar
-
ClinicalTrials.gov: Gastric Cancer | Not yet recruiting, Recruiting, Active, not recruiting studies | Phase: 3 | Interventional studies | Funded by Industry | Last update posted in the last 14 days clinicaltrials.gov
-
-
Preguntes
Quin és l’URL del feed RSS de ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?
L’adreça del feed és https://clinicaltrials.gov/api/rss?cond=Alzheimer+Disease&intr=Lecanemab+OR+donanemab+OR+Remternetug+OR+Trontinemab+OR+Crenezumab+OR+Valitramiprostate&dateField=LastUpdatePostDate. Enganxa-la en qualsevol lector RSS o fes clic a «Segueix ara» per llegir-lo a Feeder.
Amb quina freqüència publica ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?
ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days publica unes 4 vegades a la setmana. L’última publicació va ser fa 1 dia.
Funciona el feed RSS de ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days?
Sí. Feeder el va comprovar fa 9 minuts i el feed va respondre amb normalitat.
Com puc seguir ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days a Feeder?
Fes clic a «Segueix ara» i registra’t si encara no tens cap compte. El pla gratuït de Feeder inclou fins a 200 feeds, al web, l’iPhone i Android. No cal targeta de crèdit.
Segueix ClinicalTrials.gov: Alzheimer Disease | Lecanemab OR donanemab OR Remternetug OR Trontinemab OR Crenezumab OR Valitramiprostate | Last update posted in the last 14 days a Feeder
El pla gratuït de Feeder inclou fins a 200 feeds, al web, l’iPhone i Android. No cal targeta de crèdit.